New methods for early diagnosis of lung cancer

Lung Cancer

Volumn 38, Issue 1, 2002, Pages S9-

  Van Zandwijk, Nico ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Conventional treatment; Early diagnosis; Lung cancer

Indexed keywords

BIOLOGICAL MARKER;

AUTOFLUORESCENCE; BRONCHOSCOPY; BRONCHUS; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONFERENCE PAPER; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; LUNG CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SPUTUM;

EID: 0036806572     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00245-3     Document Type: Conference Paper

References (20)

1. Peto R., Lopez A.D., Boreham J., Thun M., Heath C., Doll R. Mortality from smoking worldwide. Br. Med. Bull. 52:1996;12-21.
2. Kato H. Photodynamic therapy for early stage central type of lung cancer. Mayo Clin. Proc. 72:1997;688-690.
3. Cortese D.A., Edell E.S., Kinsey J.H. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin. Proc. 72:1997;595-602.
4. Speiser B.L. Brachytherapy in the treatment of thoracic tumors. Lung and esophageal. Hematol. Oncol. Clin. North Am. 13:1999;609-634.
5. Mao L., Lee J.S., Kurie J.M., et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89:1997;857-862.
6. Kaneko M., Eguchi K., Ohmatsu H., et al. Periferal lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology. 201:1996;798-802.
7. Sone S., Li F., Yang Z.-G., et al. Results of 3-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br. J. Cancer. 84:2001;25-32.
8. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early Lung Cancer Project: overall design and findings from baseline screening. Lancet. 354:1999;99-105.
9. Miettinen O.S., Henschke C.I. CT screening for lung cancer: coping with nihilistic recommendations. Radiology. 221:2001;592-596.
10. Altorki NK. Abstract Turin.
11. Lam S., Hung J.Y., Kennedy S.M., et al. Detection of dysplasia and carcinoma in situ by ratio fluorometry. Am. Rev. Respir. Dis. 146:1992;1458-1461.
12. Kennedy T.C., Lam S., Hirsch F.R. Review of recent advances in fluorescence bronchoscopy in early localization of central airway cancer. Oncologist. 6:2001;257-262.
13. Ikeda N. Abstract Turin.
14. Becker H.D. Bronchoscopy. Year 2000 and beyond. Clin. Chest Med. 22:2001;225-239.
15. Fujimoto J.G., Pitris C., Boppart S., Brezinski M. Optical coherence tomography, an emerging technology for biomedical imaging and optical biopsy. Neoplasia. 2:1997;9-25.
16. Hirsch FR, Prindiville SA, Byers T. et al. Sputum cytology and bronchial histology as risk markers for early detection of lung cancer - Preliminary results from the University of Colorado high risk cohort study. Abstract Turin.
17. van Zandwijk N., Hirsch F.R. Chemoprevention strategies for non-small cell lung cancer. Curr. Opin. Oncol. 14:2002;185-190.
18. The Leuven Lung Cancer Study Group, Vansteenkiste J.F., Strobants S.G., Dupont G.J., et al. Prognostic importance of the standardized uptake of (18)-fluoro-2-deoxy-glucose-positron emission tomography in non-small cell lung cancer: an analysis of 125 cases. J. Clin. Oncol. 17:1999;3201-3206.
19. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperativer staging of non-small-cell lung cancer with positron-emission tomography. New Engl. J. Med. 343:2000;254-261.
20. The PLUS Study Group, van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 359:2002;1388-1392.